Intraindividual variability in lipoprotein(a): the value of a repeat measure for reclassifying individuals at intermediate-risk

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Tarek Harb

The Johns Hopkins University School of Medicine, Baltimore (United States of America)

4 More presentations in this session

Presentation thumbnail

Lipoprotein(a) metabolomic and proteomic features and atherosclerotic cardiovascular disease in young, asymptomatic adults

Associate Professor S. Goonewardena (Ann Arbor, US)

Abstract Slides Video

Presentation thumbnail

Combination therapy with GalNAc-siRNA drugs targeting both PCSK9 and APOC3 resulted in enhanced lipid lowering in mice

Doctor J. Wikstrom (SE)

Abstract Slides Video

Presentation thumbnail

Reduction of triglyceride-rich lipoproteins with retatrutide in type 2 diabetes may be explained by concurrent reduction in ANGPTL3/8 levels

Doctor G. Ruotolo (Indianapolis, US)

Abstract Slides Video

Presentation thumbnail

Metabolomic profiling of the entire UK Biobank enables interpretation of familial hypercholesterolemia mutations and prediction of severe cardiovascular outcomes

Doctor J. Barrett (Helsinki, FI)

Abstract Slides Video

Access the full session

Session thumbnail

Lipids as cardiovascular risk factors and treatment options

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Presentation

Advancements and challenges in cardiovascular risk stratification: an overview of cardiac biomarkers

Webinar

Biomarkers of clinical utility in cardiovascular disease

Congress Session

Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources